Sheva Pekar is the founder and CEO of PsyCann. Her mission is to simplify the business process for startup cannabis entrepreneurs and create accessible and equitable regulatory models for legal psychedelics. PsyCann was born as a bridge between business leaders and regulators.
Sheva has assembled an outstanding team of experienced cannabis industry professionals to bring PsyCann Advisors signature blend of knowledge, innovation and deep client-first attitude to ensure each client’s business is both competitive and up to regulatory expectations.
We are passionate about developing custom and personalized service packages using our expertise and experience to seamlessly align your business’s cannabis and psychedelic vision with current regulations and industry standards.
Sheva Pekar is the founder, CEO and visionary of PsyCann Advisors, a consulting firm that focuses on the licensing and compliance and regulations of the cannabis and psychedelic industries.
PsyCann Advisors is dedicated to entrepreneurs in growing and visionary industries.
Sheva has 6 years of strategic experience in the cannabis industry with state-licensed facilities in all facets of their business and 3 years of behind the scene psychedelic industry work that exploded from Denver Colorado. She has a versatile and service-minded approach advocating for her clients.
Her experience includes business development, project management, inventory management, SOP development, business plan development, wholesale, client advocacy, metrc and compliance support and licensing and application help.
Her approach to cannabis and psychedelic industries is rooted in an infinite-minded leadership model of trust and confidence gained from clients and colleagues.
Visit PsyCann Website
Like our Fanpage
Follow on LinkedIn
Psychedelic drugs have the potential to transform mental health and addiction treatments. Initial research has shown positive results for individuals suffering from cluster headaches, depression, anxiety, PTSD, OCD, ADHD, and alcoholism. It is predicted that legal psychedelics will be a multi-billion-dollar industry. Forbes
The Psychedelic Drugs Market size is projected to reach USD 10.75 Bn by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027. Researchandmarkets.com
This intensive, four-part online workshop presents a 360-view of the psychedelic ecosystem and an opportunity to collaborate and interact with other leaders and professionals. You’ll dive deep into the history of psychedelic research and use, learn about today’s regulatory and therapeutic practices on the local, state, national and international stages, and get a glimpse into the future of tomorrow’s psychedelic landscape and the exciting business opportunities that are blossoming. We are bringing community members, professionals, entrepreneurs, and visionaries together as the movement unfolds through inspiring, interactive workshops that provide you the opportunity to develop your foundation of knowledge and plan proactively for the future.
Four Saturdays 9:00 – 11:00 am Limited to 20 Attendees
Session I – State of the Union On Psychedelics
Session 2 – The Present
Our Challenge: Mental Health and Social Equity
The movement to decriminalize psilocybin catalyzed a new psychedelic awareness that created a brand new ecosystem filled with incredible potential. This ecosystem and the industry forming inside of it is uniquely suited to address some of the most challenging and pervasive issues in our culture. As leaders and innovators, we get to design an inclusive and equitable industry centered on addressing our society’s vast mental health crisis.
- How is the psychedelic industry positioned to serve these challenges?
- What steps are currently being taken to address these major struggles?
- Who are the main players in the current psychedelic landscape? What are their interests and what do they contribute to the industry?
Session 3 – Tapping the Brain Trust
Conversations About the Future With Industry Visionaries
Session 4 – The Future, and You
Empowering Through Community Engagement
As leaders and innovators we have an opportunity, and an ethical responsibility, to curate an industry that is centered on social equity and mental health as guiding principles for our work. The collective power of our professional efforts and business acumen can influence regulations, and if aligned, we can prevent repeating some of the same regulatory ignorance that has occurred in the cannabis industry.
During this session, we will facilitate workshops, brainstorming, collaboration, and harness our power to design the psychedelic industry to reflect and amplify our holistic and community-focused goals.
Let’s use our cannabis experience and create a new story!
Entering the Emerging Psychedelic Market
Non Members $2100
Entering the Emerging Psychedelics Market
These questions will guide our work together:
What drives your interest in the psychedelic industry?
What is your vision in psychedelics?
How do you want your professional and personal experience to translate into this vision?
What are your unknowns? Preconceptions?
How do we define success in this industry?
How do we, as professionals and industry leaders, solve the present day challenges?
How do we use lessons learned in the cannabis industry to create an industry centered on mental health and equitable access?
The Entering the Emerging Psychedelic Market Workshop is presented in a Live Virtual Classroom. To provide more of an in person classroom experience, we are limiting participants to 20 per course or workshop. The structure of each course and workshop facilitates the interaction between the participants and the educator. The curriculums are developed to deliver relevant and precise knowledge that will fast track participants’ career and business success.
Refund Policy: Full Refund if canceled within 15 days of course date. 80% Refund if cancelled less than 15 days prior to course. firstname.lastname@example.org